NSE:SPARC

Sun Pharma Advanced Research Company Limited · NSE · Healthcare · INR · FY for 2026

Figures on this page computed 2026-11-08 13:15 UTC

Last close

n/aINR

Market data

4.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
82.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
-15.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Follow one rupee

lens 1 of 9

After what it costs to make

91.9%

After running the business

84.5%

After interest and tax

82.7%

After what it must reinvest

-15.8%

Kept after the dividend

n/a

after what it costs to make, 91.9% of sales; after running the business, 84.5% of sales; after interest and tax, 82.7% of sales; after what it must reinvest, -15.8% of sales

The five stops

4 of 5 read

After what it costs to make17,273,300,00091.9%
After running the business15,885,500,00084.5%
After interest and tax15,532,000,00082.7%
After what it must reinvest-2,967,900,000-15.8%
Kept after the dividendn/an/a

The last stop is empty on purpose. This filing does not tag a common dividend, so what is kept after it cannot be worked out. That is not the same fact as a company that paid no dividend, and we will not print a zero for it.

What is left after the dividend is not held for this company.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales18,791,700,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After what it costs to make17,273,300,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After running the business15,885,500,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After interest and tax15,532,000,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After what it must reinvest-2,967,900,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
Kept after the dividendn/a
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR